Publication:
COVİD-19 infection in a membranous nephropathy patient treated with rituximab.

Simple item page
dc.contributor.authorElcioglu, Omer Celal
dc.contributor.authorArtan, Ayse Serra
dc.contributor.authorMirioglu, Safak
dc.contributor.authorGursu, Meltem
dc.contributor.authorDurdu, Bulent
dc.contributor.authorKoc, Meliha Meric
dc.contributor.authorOkyaltirik, Fatmanur
dc.contributor.authorGultekin, Mehmet Ali
dc.contributor.authorKazancioglu, Rümeyza
dc.contributor.institutionauthorELÇİOĞLU, ÖMER CELAL
dc.contributor.institutionauthorMİRİOĞLU, ŞAFAK
dc.contributor.institutionauthorGÜRSU, MELTEM
dc.contributor.institutionauthorDURDU, BÜLENT
dc.contributor.institutionauthorMERİÇ KOÇ, MELİHA
dc.contributor.institutionauthorOKYALTIRIK, FATMANUR
dc.contributor.institutionauthorGÜLTEKİN, MEHMET ALİ
dc.contributor.institutionauthorKAZANCIOĞLU, RÜMEYZA
dc.date.accessioned2020-09-07T20:59:07Z
dc.date.available2020-09-07T20:59:07Z
dc.date.issued2020-09-04T00:00:00Z
dc.description.abstractWhile COVID-19 pandemic continues to afect our country and most countries in the world, we have to make some changes both in our social life and our approach to healthcare. We have to struggle with the pandemic on one hand and also try to follow up and treat our patients with chronic diseases in the most appropriate way. In this period, one of our group of patients who are challenging us for follow-up and treatment are those who should start or continue to use immunosuppressive therapy. In order to contribute to the accumulation of knowledge in this area, we wanted to report a patient who was followed up with the diagnosis of COVID-19 and had been administered rituximab very recently due to a nephrotic syndrome caused by membranous nephropathy.
dc.identifier.citationElcioglu O., Artan A., Mirioglu S., Gursu M., Durdu B., Meric K., Okyaltirik F., Gultekin M., Kazancioglu R., -COVİD-19 infection in a membranous nephropathy patient treated with rituximab.-, CEN case reports, 2020
dc.identifier.doi10.1007/s13730-020-00524-3
dc.identifier.pubmed32888168
dc.identifier.urihttp://hdl.handle.net/20.500.12645/18599
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472945/
dc.language.isoen
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCoronavirus
dc.subjectCOVID-19
dc.subjectImmunosuppression
dc.subjectMembranous nephropathy
dc.subjectRituximab
dc.titleCOVİD-19 infection in a membranous nephropathy patient treated with rituximab.
dc.typeArticle
dspace.entity.typePublication
local.avesis.idbbb08e99-b845-4aa0-a6cd-0abd620200f3
local.indexed.atPubMed
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublicationac752d9f-ce71-4152-9eec-135f3d2a7a18
relation.isAuthorOfPublication1a6fde04-64ba-4074-8a18-b696ffbbbd3e
relation.isAuthorOfPublicationa6446eac-0ccd-4457-9227-3fc72dec68d1
relation.isAuthorOfPublication9814f802-a79c-45fd-aa3e-f1ba9d40884b
relation.isAuthorOfPublicationdd6ca7f4-a1a6-4c91-9a61-e55f1118b6d9
relation.isAuthorOfPublication7dbc11df-6a75-478d-8155-e4857d7ed807
relation.isAuthorOfPublication6b9cc84c-3e9f-4bba-ae97-b0dd0af0f6d3
relation.isAuthorOfPublicationeca7bd30-6b6e-444d-96ae-2961c39f2107
relation.isAuthorOfPublication.latestForDiscoverya6446eac-0ccd-4457-9227-3fc72dec68d1
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
COVİD-19 infection in a membranous nephropathy patient treated with rituximab.pdf
Size:
947.02 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Yayınlar - Eserler